RESCUING

Elaborate insights

RESCUING’s outcomes will help identify the optimal treatments and clinical management procedures. They will also help identify the patient categories and clinical centers that can be used to optimize future Phase II / Phase III clinical trials of novel candidate drugs.

The study will provide detailed insights into such things as:

• demographical and clinical characteristics of ICU-patients who develop cUTI;
• risk factors associated with developing cUTI;
• current clinical management of patients with complicated urinary tract infections;
• risk factors associated with early treatment failures;
• duration of patients’ hospital stays and antibiotic therapies;
• mortality rates;
• costs involved in the clinical management of multidrug-resistance problems.

Each patient record in the study contains information about demographics, comorbidities, functional capacity, place of infection and predisposing risk factors. It also contains clinical data, clinical pathology data, microbiological data, imaging test data, data on infection management, antibiotic therapy and clinical outcomes. As well as details of discharge and, if applicable, of readmission and/or death. All patients were followed up for up to two months after their discharge from the hospital.